Common candidate profiles include: Adults aged 35 to 70 noticing declining energy, strength, or recovery capacity Individuals with stubborn abdominal fat and metabolic resistance despite healthy habits Patients with low-normal growth hormone or testosterone who want to avoid full hormone replacement Women in perimenopause or early menopause struggling with sleep, mood, sexual wellness, or weight gain People seeking weight loss support when diet and exercise have plateaued Peptide therapy addresses weight management from multiple angles, including appetite regulation, fat metabolism optimization, and muscle preservation
Les essais cliniques montrent en gnral une frquence absolue de 0,3 % chez l es participants , trs proche dune incidence normale dans la population gnrale (0,2%)
GLP-1 medications like Wegovy and Zepbound work with your bodys natural processes to support weight loss and metabolic health
Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB